Search research articles
Contact Us
Filters
Showing results (441-450 of 476) with videos related to
Page
of 48
Sort By:
Cancer Cell
|
February 5, 2010
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, et al.
Cancer Discovery
|
June 18, 2016
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
Haikuo Zhang, Jun Qi, Jaime M Reyes, et al.
The Lancet. Oncology
|
November 5, 2020
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
Aleix Prat, Valentina Guarneri, Laia Paré, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 5, 2025
Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer
Frederick M Howard, James Dolezal, Hanna Hieromnimon, et al.
Cell
|
August 12, 2014
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
Katherine A Hoadley, Christina Yau, Denise M Wolf, et al.
Breast Cancer Research and Treatment
|
December 27, 2011
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Laura J Esserman, Donald A Berry, Maggie C U Cheang, et al.
Nature
|
June 3, 2016
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins, D R Mani, Kelly V Ruggles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2018
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Priyanka Sharma, Sara López-Tarruella, José Angel García-Saenz, et al.
The Lancet. Oncology
|
July 17, 2025
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
Guillermo Villacampa, Tomás Pascual, Paolo Tarantino, et al.
Molecular & Cellular Proteomics : MCP
|
December 4, 2015
An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer
Kelly V Ruggles, Zuojian Tang, Xuya Wang, et al.
Page
of 48
Search research articles
Search
Showing results (441-450 of 476) with videos related to
Sort By:
Page
of 48
Cancer Cell
|
February 5, 2010
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, et al.
Cancer Discovery
|
June 18, 2016
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
Haikuo Zhang, Jun Qi, Jaime M Reyes, et al.
The Lancet. Oncology
|
November 5, 2020
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
Aleix Prat, Valentina Guarneri, Laia Paré, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 5, 2025
Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer
Frederick M Howard, James Dolezal, Hanna Hieromnimon, et al.
Cell
|
August 12, 2014
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
Katherine A Hoadley, Christina Yau, Denise M Wolf, et al.
Breast Cancer Research and Treatment
|
December 27, 2011
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Laura J Esserman, Donald A Berry, Maggie C U Cheang, et al.
Nature
|
June 3, 2016
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins, D R Mani, Kelly V Ruggles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2018
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Priyanka Sharma, Sara López-Tarruella, José Angel García-Saenz, et al.
The Lancet. Oncology
|
July 17, 2025
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
Guillermo Villacampa, Tomás Pascual, Paolo Tarantino, et al.
Molecular & Cellular Proteomics : MCP
|
December 4, 2015
An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer
Kelly V Ruggles, Zuojian Tang, Xuya Wang, et al.
Page
of 48